Important Disclaimer and Facts about BiotechDueDiligence
BiotechDueDiligence is an informal site to gather, evaluate, share, and discuss information about publicly-traded biotechnology companies. The information contained on this site is not a specific recommendation for any individual or entity to buy or sell any particular investment. This website is first and foremost a venue for biotech investors and enthusiasts to learn the skills needed to properly evaluate biotechnology, pharmaceuticals, and genomics investment opportunities. You must do your own research and evaluate each investment opportunity in regards to your personal situation. All information presented on the BiotechDueDiligence site is based on publicly-available resources - I may dig deep in conducting research, but there is no insider information on this site.
Any opinions or statements expressed by Dr. Andrew Goodwin are personal and do not represent the opinion of or an endorsement by the United States Food and Drug Administration (FDA), Johns Hopkins University School of Medicine, the Johns Hopkins Hospital and Health System. As an FDA employee, Andrew is prohibited from holding financial interests in any companies considered to be “significantly regulated” by the FDA [which includes virtually all stocks discussed on BiotechDueDiligence]. Further, the reader understands that any opinions of statements made by Dr. Goodwin will not contain confidential information or details about internal FDA policies and procedures.
The editor of and contributors to BiotechDueDiligence will disclose any holdings in stocks they discuss - always take this information into consideration. All information on this website is only current to the best of our knowledge and ability as of the date indicated and may not reflect accurately recent events.
There is no corporate sponsorship of BiotechDueDiligence and we do not accept promotional or paid content or blog entries. All advertising displayed on the website is controlled and sourced by third-party providers such as Google Adsense. We do not control nor endorse what advertisements appear on the site, but it is our hope that they are pertinent and useful to our visitors.
Any opinions or statements expressed by Dr. Andrew Goodwin are personal and do not represent the opinion of or an endorsement by the United States Food and Drug Administration (FDA), Johns Hopkins University School of Medicine, the Johns Hopkins Hospital and Health System. As an FDA employee, Andrew is prohibited from holding financial interests in any companies considered to be “significantly regulated” by the FDA [which includes virtually all stocks discussed on BiotechDueDiligence]. Further, the reader understands that any opinions of statements made by Dr. Goodwin will not contain confidential information or details about internal FDA policies and procedures.
The editor of and contributors to BiotechDueDiligence will disclose any holdings in stocks they discuss - always take this information into consideration. All information on this website is only current to the best of our knowledge and ability as of the date indicated and may not reflect accurately recent events.
There is no corporate sponsorship of BiotechDueDiligence and we do not accept promotional or paid content or blog entries. All advertising displayed on the website is controlled and sourced by third-party providers such as Google Adsense. We do not control nor endorse what advertisements appear on the site, but it is our hope that they are pertinent and useful to our visitors.
BiotechDueDiligence is a completely free site. The only compensation received for the hundreds of hours of effort that have gone into building this resource is in the form of revenue from ad clicks and from donations from appreciative visitors. BiotechDueDiligence is also a member of the Amazon Associates program and earns advertising fees when you click on Amazon.com links on website or social media channels and make a purchase.
